Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

The Role of Patent Foramen Ovale in Cryptogenic Stroke.

Şenadim S, Bozkurt D, Çabalar M, Bajrami A, Yayla V.

Noro Psikiyatr Ars. 2016 Mar;53(1):63-66. doi: 10.5152/npa.2015.10034. Epub 2016 Mar 1.

2.

Significance of Echocardiographically Detected Central Venous Catheter Tip-Associated Thrombi.

Chick JF, Reddy SN, Bhatt RD, Shin BJ, Kirkpatrick JN, Trerotola SO.

J Vasc Interv Radiol. 2016 Dec;27(12):1872-1877. doi: 10.1016/j.jvir.2016.07.013. Epub 2016 Sep 19.

PMID:
27659895
3.

Cryptogenic postpartum stroke.

Bereczki D Jr, Szegedi N, Szakács Z, Gubucz I, May Z.

Neurol Neurochir Pol. 2016;50(5):370-3. doi: 10.1016/j.pjnns.2016.05.001. Epub 2016 May 18.

PMID:
27591063
4.

Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.

Davies A, Ekmejian A, Collins N, Bhagwandeen R.

Heart Lung Circ. 2017 Mar;26(3):246-250. doi: 10.1016/j.hlc.2016.06.1211. Epub 2016 Aug 5.

PMID:
27555053
5.

Recurrent Stroke due to Patent Foramen Ovale Closure Device Thrombus Eight Years after Implantation.

Kodankandath TV, Mishra S, Libman RB, Wright P.

J Stroke Cerebrovasc Dis. 2016 Sep;25(9):e161-2. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.037. Epub 2016 Jul 18.

PMID:
27444520
6.

Patent foramen ovale.

Homma S, Messé SR, Rundek T, Sun YP, Franke J, Davidson K, Sievert H, Sacco RL, Di Tullio MR.

Nat Rev Dis Primers. 2016 Jan 21;2:15086. doi: 10.1038/nrdp.2015.86. Review.

PMID:
27188965
7.

PFO: Button me up, but wait … Comprehensive evaluation of the patient.

Pizzino F, Khandheria B, Carerj S, Oreto G, Cusmà-Piccione M, Todaro MC, Oreto L, Vizzari G, Di Bella G, Zito C.

J Cardiol. 2016 Jun;67(6):485-92. doi: 10.1016/j.jjcc.2016.01.013. Epub 2016 Feb 23. Review.

PMID:
26917197
8.

Patent Foramen Ovale and Stroke-Current Status.

Bang OY, Lee MJ, Ryoo S, Kim SJ, Kim JW.

J Stroke. 2015 Sep;17(3):229-37. doi: 10.5853/jos.2015.17.3.229. Epub 2015 Sep 30. Review.

9.

Closing patent foramen ovale in cryptogenic stroke: The underscored importance of other interatrial shunt variants.

Rigatelli G, Rigatelli A.

World J Cardiol. 2015 Jun 26;7(6):326-30. doi: 10.4330/wjc.v7.i6.326. Review.

10.

Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.

Mirzaali M, Dooley M, Wynne D, Cooter N, Lee L, Haworth P, Saha R, Gainsborough N, Hildick-Smith D.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1078-84. doi: 10.1002/ccd.26080. Epub 2015 Jun 23.

PMID:
26105198
11.

How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke.

Falanga G, Carerj S, Oreto G, Khandheria B, Zito C.

J Cardiovasc Echogr. 2015 Apr-Jun;25(2):46-53. doi: 10.4103/2211-4122.161779. Review.

12.

Percutaneous patent foramen ovale closure: the Paradoxical Cerebral Embolism Prevention Registry.

Paiva L, Dinis P, Providência R, Costa M, Margalho S, Goncalves L.

Rev Port Cardiol. 2015 Mar;34(3):151-7. doi: 10.1016/j.repc.2014.08.009. Epub 2015 Feb 27. English, Portuguese.

PMID:
25727752
13.

Impact of transesophageal echocardiography on management in patients with suspected cardioembolic stroke.

Khariton Y, House JA, Comer L, Coggins TR, Magalski A, Skolnick DG, Good TH, Main ML.

Am J Cardiol. 2014 Dec 15;114(12):1912-6. doi: 10.1016/j.amjcard.2014.09.035. Epub 2014 Sep 26.

PMID:
25438921
14.

Embolization of patent foramen ovale closure devices: incidence, role of imaging in identification, potential causes, and management.

Goel SS, Aksoy O, Tuzcu EM, Krasuski RA, Kapadia SR.

Tex Heart Inst J. 2013;40(4):439-44. Review.

15.

Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials.

Hakeem A, Marmagkiolis K, Hacioglu Y, Uretsky BF, Gundogdu B, Leesar M, Bailey SR, Cilingiroglu M.

Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):349-55. doi: 10.1016/j.carrev.2013.08.010. Epub 2013 Sep 27. Review.

PMID:
24080379
16.

Patent foramen ovale and cryptogenic stroke: the hole story.

Furlan AJ, Jauss M.

Stroke. 2013 Sep;44(9):2676-8. doi: 10.1161/STROKEAHA.113.001676. Epub 2013 Aug 1.

17.

Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.

Hornung M, Bertog SC, Franke J, Id D, Taaffe M, Wunderlich N, Vaskelyte L, Hofmann I, Sievert H.

Eur Heart J. 2013 Nov;34(43):3362-9. doi: 10.1093/eurheartj/eht283. Epub 2013 Jul 9.

PMID:
23842846
18.

Management of the stroke patient with patent foramen ovale: new insights and persistent questions in the wake of recent randomized trials.

Peña JM, Kizer JR.

Curr Atheroscler Rep. 2013 Jul;15(7):338. doi: 10.1007/s11883-013-0338-4. Review.

PMID:
23715857
19.
20.

Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry.

Horner S, Niederkorn K, Gattringer T, Furtner M, Topakian R, Lang W, Maier R, Gamillscheg A, Fazekas F.

J Neurol. 2013 Jan;260(1):260-7. doi: 10.1007/s00415-012-6629-9. Epub 2012 Aug 5.

PMID:
22865239

Supplemental Content

Loading ...
Support Center